Virginia (Ginny) has worked in industry and academia throughout her career, combining interests in science policy research and innovation performance within and across organizations. She joined MSD in 2017 to lead regulatory policy efforts for innovation that will lead to better treatment for patients globally. Before joining MSD, Ginny was the senior spokesman for the industry in the UK for research, medical and innovation policy (including BREXIT). Previously, Ginny worked for Amgen in global regulatory policy and for Pfizer working on policy development in science and innovation in healthcare.
Geneticist and Forensic Expert